# Lamivudine

NDC: 68180-602
Generic name: Lamivudine
Labeler / Manufacturer: Lupin Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20150325

FDA application: ANDA205217

## Active ingredients

- LAMIVUDINE: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68180-602"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68180-602
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ff3b5265-f533-4332-a861-d8c9c1664ffd